Vir Biotechnology (VIR) Accumulated Expenses (2018 - 2026)
Vir Biotechnology (VIR) recorded Accumulated Expenses of $77.21 million in Q2 2026, down 6.6% from $82.66 million a year earlier but up 13.4% from the prior quarter.
Vir Biotechnology (VIR) Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Vir Biotechnology reported Accumulated Expenses of $83.01 million, down 15.7% from FY2024.
- Annual Accumulated Expenses has declined for three straight years, though with a five-year compound annual growth rate of 1.5% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $98.52 million in FY2024 (-5.5%), $104.22 million in FY2023 (-78.7%), $489.09 million in FY2022 (+106.8%) and $236.51 million in FY2021 (+207.4%).
- Quarterly Accumulated Expenses has ranged from $64.85 million in Q3 2021 to $577.67 million in Q1 2022 over the past five years.
- On a year-over-year basis, Accumulated Expenses has declined for four consecutive quarters, with an average decline of 8.9% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 724.4% in Q1 2022, against a decline of 84.2% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $68.11 million (Q1 2026), $83.01 million (Q4 2025) and $68.38 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.21 Mn |
| Mar 31, 2026 | 68.11 Mn |
| Dec 31, 2025 | 83.01 Mn |
| Sep 30, 2025 | 68.38 Mn |
| Jun 30, 2025 | 82.66 Mn |
| Mar 31, 2025 | 104.13 Mn |
| Dec 31, 2024 | 98.52 Mn |
| Sep 30, 2024 | 94.66 Mn |
| Jun 30, 2024 | 75.32 Mn |
| Mar 31, 2024 | 72.26 Mn |
| Dec 31, 2023 | 104.22 Mn |
| Sep 30, 2023 | 146.11 Mn |
| Jun 30, 2023 | 197.58 Mn |
| Mar 31, 2023 | 455.92 Mn |
| Dec 31, 2022 | 489.09 Mn |
| Sep 30, 2022 | 282.62 Mn |
| Jun 30, 2022 | 354.09 Mn |
| Mar 31, 2022 | 577.67 Mn |
| Dec 31, 2021 | 236.51 Mn |
| Sep 30, 2021 | 64.85 Mn |
Vir Biotechnology Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();